Posted by & filed under Company Analysis, Financial analysis, Growth & Valuation, Industry Analysis.

Description: Should Bill Ackman and Valeant Pharmaceuticals International Inc. fail in their bid to take over Allergan Inc., options traders will be hedged.


Date: Aug 28, 2014


Questions for Discussions:

  • What does this report say about the various strategies in play?
  • What would you advise investors to do at this time?

Leave a Reply

Your email address will not be published. Required fields are marked *